AbCellera Biologics Inc. Files 2024 DEF 14A
Ticker: ABCL · Form: DEF 14A · Filed: Apr 29, 2025 · CIK: 1703057
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
TL;DR
AbCellera's 2024 DEF 14A is out, detailing exec pay. Keep an eye on those numbers.
AI Summary
AbCellera Biologics Inc. filed its DEF 14A on April 29, 2025, for the fiscal year ending December 31, 2024. The filing provides details on executive compensation and other corporate governance matters. The company is based in Vancouver, BC, and operates in the pharmaceutical preparations industry.
Why It Matters
This filing is important for shareholders as it details executive compensation, which can impact company performance and investor confidence.
Risk Assessment
Risk Level: low — This filing is a routine annual disclosure and does not contain immediate, significant financial risks.
Key Players & Entities
- AbCellera Biologics Inc. (company) — Filer
- 2024-12-31 (date) — Fiscal Year End
- 20250429 (date) — Filing Date
- Vancouver (location) — Company Headquarters
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Proxy Statement, is used to solicit proxies from shareholders for an upcoming annual meeting, providing information on matters to be voted on, including executive compensation and director elections.
When did AbCellera Biologics Inc. file its most recent DEF 14A?
AbCellera Biologics Inc. filed its DEF 14A on April 29, 2025.
What fiscal year does this DEF 14A filing cover?
This DEF 14A filing covers the fiscal year ending December 31, 2024.
Where is AbCellera Biologics Inc. headquartered?
AbCellera Biologics Inc. is headquartered at 150 W 4th Avenue, Vancouver, BC, V5Y 1G6.
What is the Standard Industrial Classification (SIC) code for AbCellera Biologics Inc.?
The SIC code for AbCellera Biologics Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 29, 2025 regarding AbCellera Biologics Inc. (ABCL).